x 

0 Activities
0 Activities
    • No Saved Activities

Pulmonology

  2. Home
  3. Education
  4. Top Specialty Areas
  5. Pulmonology

Search

Saved Activities

 x 

0 Activities
0 Activities
    • No Saved Activities

Filter Content

Page 2 of 4
Results 76 - 150 of 271
No image set
COVID-19 and ARDS: West Coast Experiences
No image set
Biochemical Profiles of Radiographic Patterns in SSc-ILD
No image set
Factors Associated with Disease Progression in the SENSCIS Trial
No image set
Machine Learning Assisted Prediction of Progression in SSc-ILD
No image set
What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD
No image set
Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD
No image set
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
No image set
Updates on Current Treatment Options for RA-ILD
cc4
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
PILOTforPulmonary 2019: Data, Insights & Practice
No image set
Managing the Whole Patient with COPD: An Animated Video Series
No image set
My COPD Action Plan
No image set
Expert Recommendations for COPD
No image set
Palliative Embolization
No image set
Vertebroplasty and Vertebral Augmentation for Spine Metastases or Pathologic Fractures
No image set
Effective Communication With Your Patient and Family
No image set
Palliative Ablations of Bone and Soft Tissue Tumors
9913-nacfc3
How Can Targeting the Endocannabinoid System Help to Resolve CF Inflammation
9913-nacfc2
Previous Approaches that Tried to Target Inflammation in Cystic Fibrosis
9913-nacfc1
Inflammation in Cystic Fibrosis
No image set
Understanding the Endocannabinoid System (Cystic Fibrosis)
No image set
SMA Updates from Around the World
9920-0004-conf_covg_icon_263x149
Updates in SMA from Charlotte, North Carolina
No image set
Surgical and Minimally Invasive Procedures that Might Benefit COPD Patients
No image set
COPD: Fixed Dose Combinations
No image set
COPD: Proper Inhaler Use
No image set
Clinical Pearls from New Orleans 2019
No image set
Inhaled NO in Patients at Risk for Pulmonary Hypertension
No image set
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
No image set
Considerations for Geriatric ILD Patients
No image set
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
No image set
Emerging Diagnostic Approaches to Patients with ILD
No image set
Goals of Care Across the Disease Continuum in IPF
No image set
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
No image set
Current Perspective on Antifibrotic Therapy for Patients with IPF
No image set
Technology Improving SMA Patients’ Quality of Life
No image set
Nusinersen Treatment Outcomes in Later-Onset SMA
No image set
Patients with Severe SMA Need Additional Respiratory Management
Castro_02
Clear Expectations Needed in SMA Patient Management
9920-264x150
The Changing Landscape of SMA–Updates from Copenhagen, Denmark
No image set
Pulmonologists as the Gatekeepers of Precision Medicine
No image set
Interstitial Pneumonia with Autoimmune Features (IPAF)
No image set
How to Identify & Manage Patients with Progressive-Fibrosing ILD
9840-0004-icon
Acute Exacerbations of IPF
9916-cme-icon
Personalized Medicine for Improving Asthma Care: An Animated Video Series
9815-developments
New Developments in Pulmonary Diseases: Optimizing Patient Outcomes
9815-palliative slides
Palliative Medicine in Pulmonology
No image set
Patient Education, Adherence, Inhaler Technique, and Pulmonary Rehabilitation
No image set
Dyspnea and Disease are Progressing: What to Do?
No image set
Thoracic Radiology
No image set
A Closer Look at ILD, Sarcoidosis, and CTEPH
No image set
New Developments in Pulmonary Diseases: Optimizing Patient Outcomes
9916-0005-icon
Discussions with Patients to Optimize Asthma Control
9916-0004_treatment
Who Should be Targeted For Treatment With Biologic Therapy?
9916-0003_endotypes
Endotypes and Phenotypes in Asthma
9916-0002_moa3
Mechanisms of Action of Biologic Therapies for Severe Asthma
9916-0001_meds
Approved Medications for the Treatment of Severe Asthma
9907-0006_shared
Engage Your Patients in Shared Decision-Making
9907-0005_cardio
Is It IPF or Cardiovascular Disease?
9907-0004_ip
Interstitial Pneumonia with Autoimmune Features
9907-0003_pf-ild
How to Identify Progressive Fibrosing ILD
9907-0002_ctd
When Is It a Connective Tissue Disease?
9907-0001_guidelines
How to Use IPF Guidelines to Make a Diagnosis
9916-kalluri
Advanced Care Planning and Palliative Care Models for Patients with IPF
9916-kalluri
Dyspnea Assessment in Patients with IPF
9916-scholand1
Which Patients with IPF Should be on Antifibrotics?
9916-brown5
The Impact of Anticoagulation Use on IPF Patient Outcomes
9916-brown5
Patient-Centered Outcomes for Patients with IPF: Activity Monitoring
9916-solomon
Connective Tissue Disease-Related ILD is Now in the Limelight
9916-brown5
Biomarkers in IPF and Other ILDs
9840-glassberg2
Evaluation and Diagnosis of IPF
9840-glassberg1
Initial Treatment Decisions of IPF
curesma19-icon
The Changing Landscape of SMA–Updates from Anaheim, CA
9837-coolidge
What if President Calvin Coolidge Was Your Asthma Patient?
Page 2 of 4

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA

Search